{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:29:48Z","timestamp":1790191788813,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000065","name":"NINDS","doi-asserted-by":"publisher","award":["F31NS076215"],"award-info":[{"award-number":["F31NS076215"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"NIEHS","doi-asserted-by":"publisher","award":["T32ES12870"],"award-info":[{"award-number":["T32ES12870"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["T32GM008602"],"award-info":[{"award-number":["T32GM008602"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006939","name":"Emory University","doi-asserted-by":"crossref","award":["NIH\/NINDS P50-NS071669"],"award-info":[{"award-number":["NIH\/NINDS P50-NS071669"]}],"id":[{"id":"10.13039\/100006939","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Alzheimer's Disease Research Center","award":["NIH P50 AG025688"],"award-info":[{"award-number":["NIH P50 AG025688"]}]},{"name":"Yerkes Primate Center","award":["RR00165"],"award-info":[{"award-number":["RR00165"]}]},{"name":"Emory University Integrated Cellular Imaging Microscopy Core"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.nbd.2014.03.004","type":"journal-article","created":{"date-parts":[[2014,3,17]],"date-time":"2014-03-17T04:32:06Z","timestamp":1395030726000},"page":"191-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"special_numbering":"C","title":["Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease"],"prefix":"10.1016","volume":"67","author":[{"given":"Stefka","family":"Gyoneva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Lazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethel","family":"Garnier-Amblard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoland","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen F.","family":"Traynelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2014.03.004_bb0005","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ana.1052","article-title":"Prospective study of caffeine consumption and risk of Parkinson's disease in men and women","volume":"50","author":"Ascherio","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2014.03.004_bb0010","doi-asserted-by":"crossref","first-page":"9133","DOI":"10.1523\/JNEUROSCI.1820-08.2008","article-title":"Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling","volume":"28","author":"Avignone","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.03.004_bb0015","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/glia.20015","article-title":"Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure","volume":"46","author":"Barcia","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2014.03.004_bb0020","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.expneurol.2010.12.022","article-title":"Preclinical jockeying in the translational track of adenosine A2A receptors","volume":"228","author":"Barkhoudarian","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2014.03.004_bb0025","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2014.03.004_bb0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","article-title":"Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism","volume":"76","author":"Block","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2014.03.004_bb0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2014.03.004_bb0040","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/cne.22751","article-title":"Adenosine A2A receptor in the monkey basal ganglia: ultrastructural localization and colocalization with the metabotropic glutamate receptor 5 in the striatum","volume":"520","author":"Bogenpohl","year":"2012","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2014.03.004_bb0045","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/cdd.2009.131","article-title":"Adenosine signaling and function in glial cells","volume":"17","author":"Boison","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2014.03.004_bb0050","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1471-4159.2009.06425.x","article-title":"Inactivation of neuronal forebrain A2A receptors protects dopaminergic neurons in a mouse model of Parkinson's disease","volume":"111","author":"Carta","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2014.03.004_bb0055","doi-asserted-by":"crossref","first-page":"RC143","DOI":"10.1523\/JNEUROSCI.21-10-j0001.2001","article-title":"Neuroprotection by caffeine and A2A adenosine receptor inactivation in a model of Parkinson's disease","volume":"21","author":"Chen","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.03.004_bb0060","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/glia.22350","article-title":"Microglia and NEURODEGENERATION: THE ROLE OF SYSTEMIC INFLAMMATION","volume":"61","author":"Cunningham","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2014.03.004_bb0065","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/nn1472","article-title":"ATP mediates rapid mecroglial response to local brain injury in vivo","volume":"8","author":"Davalos","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2014.03.004_bb0070","doi-asserted-by":"crossref","first-page":"5402","DOI":"10.1523\/JNEUROSCI.13-12-05402.1993","article-title":"The striatopallidal neuron: a main locus for adenosine\u2013dopamine interactions in the brain","volume":"13","author":"Ferre","year":"1993","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.03.004_bb0075","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1212\/WNL.0b013e3181d5a4a3","article-title":"Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis","volume":"74","author":"Gagne","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2014.03.004_bb0080","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","article-title":"Why neurodegenerative diseases are progressice: uncontrolled inflammation drives disease progression","volume":"29","author":"Gao","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.nbd.2014.03.004_bb0085","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1212\/WNL.0b013e31820f2d79","article-title":"Use of ibuprofen and risk of Parkinson disease","volume":"76","author":"Gao","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2014.03.004_bb0090","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.03.004_bb0095","doi-asserted-by":"crossref","first-page":"15291","DOI":"10.1074\/jbc.M113.458901","article-title":"Norepinephrine modulates the motility of resting and activated microglia via different adrenergic receptors","volume":"288","author":"Gyoneva","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2014.03.004_bb0100","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/glia.10161","article-title":"Microglia as a source and target of cytokines","volume":"40","author":"Hanisch","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2014.03.004_bb0105","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1474-4422(11)70012-6","article-title":"Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double blind, randomised trial","volume":"10","author":"Hauser","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2014.03.004_bb0110","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1038\/nn1805","article-title":"The P2Y12 receptor regulates microglial activation by extracellular nucleotides","volume":"9","author":"Haynes","year":"2006","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2014.03.004_bb0115","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/glia.20874","article-title":"Microglia processes block the spread of damage in the brain and require functional chloride channels","volume":"57","author":"Hines","year":"2009","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2014.03.004_bb0120","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.nbd.2014.03.004_bb0125","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1128\/MCB.20.11.4106-4114.2000","article-title":"Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion","volume":"20","author":"Jung","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2014.03.004_bb0130","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/glia.20690","article-title":"Age and region-specific responses of microglia, but not astrocytes, suggest a role in selective vulnerability of dopamine neurons after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure in monkeys","volume":"56","author":"Kanaan","year":"2008","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2014.03.004_bb0135","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuron.2012.12.023","article-title":"Microglia: new roles for the synaptic stripper","volume":"77","author":"Kettenmann","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2014.03.004_bb0140","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","article-title":"Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease","volume":"318","author":"Kish","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nbd.2014.03.004_bb0145","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/glia.22358","article-title":"Purinergic receptors in microglia: functional modal schifts of microglia mediated by P2 and P1 receptors","volume":"61","author":"Koizumi","year":"2013","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2014.03.004_bb0150","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbi.2011.12.002","article-title":"Activation of serotonin receptors promotes microglial injury-induced motility but attenuates phagocytic activity","volume":"26","author":"Krabbe","year":"2012","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2014.03.004_bb0155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: a sensor for pathological events in the CNS","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2014.03.004_bb0160","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2014.03.004_bb0165","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0306-4522(90)90229-W","article-title":"Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain","volume":"39","author":"Lawson","year":"1990","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.03.004_bb0170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.pneurobio.2009.08.001","article-title":"The influence of microglia on the pathogenesis of Parkinson's disease","volume":"89","author":"Long-Smith","year":"2009","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2014.03.004_bb0175","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2014.03.004_bb0180","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","article-title":"Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration","volume":"54","author":"McGeer","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2014.03.004_bb0185","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(94)90508-8","article-title":"Interleukin-1\u03b2, interleukin-6, epidermal growth factor and transforming growth factor-\u03b1 are elevated in the brain from parkinsonian patients","volume":"180","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.03.004_bb0195","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/0304-3940(94)90746-3","article-title":"Tumor necrosis factor-\u03b1 (TNF-\u03b1) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients","volume":"165","author":"Mogi","year":"1994","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.03.004_bb0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3940(96)12706-3","article-title":"Interleukin (IL)-1\u03b2, IL-2, IL-4, IL-6 and transforming growth factor-\u03b1 levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease","volume":"211","author":"Mogi","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.03.004_bb0200","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0079-6123(10)83010-9","article-title":"Pathophysiological roles for purines: adenosine, caffeine and urate","volume":"183","author":"Morelli","year":"2010","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2014.03.004_bb0205","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.bmcl.2006.11.083","article-title":"Potent, selective, and orally active adenosine A2A receptor antagonists: arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines","volume":"17","author":"Neustadt","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.nbd.2014.03.004_bb0210","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1126\/science.1110647","article-title":"Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo","volume":"308","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.03.004_bb0215","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nn.2341","article-title":"Adenosine A2A receptor mediates microglial process retraction","volume":"12","author":"Orr","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2014.03.004_bb0225","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nrn1032","article-title":"The impact of systemic infection on the progression of neurodegenerative disease","volume":"4","author":"Perry","year":"2003","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2014.03.004_bb0220","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nri2015","article-title":"Systemic infections and inflammation affect chronic neurodegeneration","volume":"7","author":"Perry","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.nbd.2014.03.004_bb0230","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1600-0404.1991.tb05026.x","article-title":"Nigral degeneration in Parkinson's disease in relation to clinical features","volume":"84","author":"Rinne","year":"1991","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.nbd.2014.03.004_bb0235","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1001\/jama.283.20.2674","article-title":"Association of coffee and caffeine intake with the risk of Parkinson disease","volume":"283","author":"Ross","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.nbd.2014.03.004_bb0240","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1006\/bbrc.2001.4816","article-title":"P2Y12, a new platelet ADP receptor, target of clopidogrel","volume":"283","author":"Savi","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2014.03.004_bb0245","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.tins.2006.09.004","article-title":"Targeting adenosine A2A receptors in Parkinson's disease","volume":"29","author":"Schwarzschild","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2014.03.004_bb0250","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0006-8993(90)91055-L","article-title":"Dose-dependent destruction of the coeruleus-cortical and nigral-striatal projections by MPTP","volume":"527","author":"Seniuk","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2014.03.004_bb0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.brainres.2009.06.002","article-title":"Effect of caffeine on the expression of cytochrome P450 1A2, adenosine A2A receptor and dopamine transporter in control and 1-methyl 4-phenyl 1, 2, 3, 6-tetrahydropyridine treated mouse striatum","volume":"1283","author":"Singh","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2014.03.004_bb0260","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.nbd.2009.11.004","article-title":"Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention","volume":"37","author":"Tansey","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2014.03.004_bb0265","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2014.03.004_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2013.12.010","article-title":"Dynamic structural remodelling of microglia in health and disease: a review of the models, signals and the mechanisms","volume":"37","author":"Walker","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2014.03.004_bb0275","doi-asserted-by":"crossref","first-page":"13548","DOI":"10.1523\/JNEUROSCI.3554-06.2006","article-title":"Forebrain adenosine A2A receptors contribute to l-3,4-dihyrdoxyphenylalanine-induced dyskinesia in hemiparkinsonian mice","volume":"26","author":"Xiao","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2014.03.004_bb0280","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ana.21313","article-title":"Adenosine A2A receptor antagonists exert motor and neuroprotective effects by distinct cellular mechanisms","volume":"63","author":"Yu","year":"2008","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2014.03.004_bb0285","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s002100000309","article-title":"Extracellular metabolism of ATP and other nucleotides","volume":"362","author":"Zimmermann","year":"2000","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114000655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114000655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:08:52Z","timestamp":1760850532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996114000655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":57,"alternative-id":["S0969996114000655"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2014.03.004","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenosine A2A receptor antagonism reverses inflammation-induced impairment of microglial process extension in a model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2014.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}